Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 10.07.2025
Rubean AG
At EUR 2.54 million, Rubean AG generates more revenue in the first half of 2025 than in the entire previous year 2024
Half-year revenue of the fintech company exceeds total revenue of the previous year
Munich, July 10, 2025: The fintech company Rubean AG, Munich (ISIN: DE0005120802, WKN: 512080, symbol R1B:GR) has continued its strong revenue gro [ … ]
Thu, 10.07.2025
tonies SE
tonies® announces CFO transition and appoints first Chief Revenue Officer to accelerate international growth
tonies CFO Jan Middelhoff, who has played a pivotal role in shaping the company’s success over the last 5 years, steps down from his position for personal reasons
Hansjörg Müller, an accomplished finance leader with extensive international [ … ]
Thu, 10.07.2025
Fielmann Group AG
Fielmann Group grows sales +12% in HY1/2025, reaches profitability target, announces “Vision 2035” with €4bn sales goal for 2030
HY1/2025 figures in line with prognosis, make overachievement of Vision 2025 goals very likely
Vision 2035 envisages business evolution into a global provider of vision care and audiology
2030 targets: customer satisfac [ … ]
Thu, 10.07.2025
AGRANA Beteiligungs-Aktiengesellschaft
Financial first quarter of 2025|26: AGRANA posts predicted deterioration in earnings
First-quarter results at a glance (1 March to 31 May 2025)
Revenue: € 880.2 million (Q1 previous year: € 944.3 million)
EBIT: € 5.7 million (Q1 previous year: € 32.3 million)
EBIT margin: 0.6% (Q1 previous year: 3.4%)
Loss/profit for the period: loss of [ … ]
Thu, 10.07.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Clinical trial with ATAC candidate HDP-101 in multiple myeloma shows promising data
Cohort 7 of the Phase I dose escalation study with HDP-101 safe and well tolerated; Cohort 8 started
First patient in clinical study dosed with the second ATAC c [ … ]
Thu, 10.07.2025
Helvetia Holding AG
Helvetia Holding AG
/ Key word(s): Rating
Helvetia Holding Ltd receives first Issuer Credit Rating from S&P
10.07.2025 / 07:00 CET/CEST
Media release
St.Gallen, 10 July 2025
For the first time, Helvetia Holding AG has obtained an issuer credit rating from S&P. The rating of "A-" is derived from the "A+" financ [ … ]
Thu, 10.07.2025
Nordex SE
Q2/2025 order intake grew to 2,310 MW, compared to 1,271 MW in Q2/2024
A total of 4.5 GW of order intake for the first half of 2025 achieved
Stable pricing continued
Q2 order intake mainly from Germany, Türkiye and Latvia
Hamburg, 10 July 2025. In the second quarter of 2025 the Nordex Group secured 2,310 MW of orders in the Projects segment (ex [ … ]
Thu, 10.07.2025
Gerresheimer AG
Gerresheimer in H1 2025: Bormioli Pharma boosts revenues and earnings, continued market influences in operating business
H1 2025: Revenue +15.7%, adjusted EBITDA +11.8%
Return to organic revenue growth in Q2
Organic development compared to pro forma figures for H1 2024: Revenue -2.1%, adjusted EBITDA -6.4%
Subdued demand in the cosmetics and or [ … ]
Thu, 10.07.2025
Uweb
EQS Newswire / 10/07/2025 / 06:45 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 10 July 2025 - Uweb (University of Web3), a leading digital asset education institute, is pleased to announce the successful completion of a US$3 million angle funding round. The round was led by emerging investment firm Avenir Group, with participation from p [ … ]
Thu, 10.07.2025
Formycon AG
Press Release // July 10, 2025
Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
Streamlined clinical development program, which no longer requires a Phase III trial, is already in a far advanced stage
Last patient enrolled in Dahlia pharmacokinetic (PK) study (Last P [ … ]
